Clinical Outcome of Triheptanoin Treatment in Patients With Long-chain Fatty Acid Oxidation Disorders (LC-FAOD) Treated Under Expanded Access Program
Clinical trial NCT03768817 · COMPLETED
Trial details
- NCT number
- NCT03768817
- Sponsor
- Ultragenyx Pharmaceutical Inc
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-01-30
- Primary completion
- 2020-06-08
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.